AI to predict how bowel cancer patients will respond to new NHS drug
- Apr 15
- 1 min read
THE GUARDIAN — Researchers at London’s Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have developed the method with the goal of sparing potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers.
In the UK alone, nearly 10,000 cases of advanced bowel cancer are identified every year, with young adults seeing a particular rise in diagnoses. Bowel cancer has the second highest mortality rate of any cancer, behind only lung cancer, and while survival rates can be as high as 98% when caught early, the five-year survival rate for advanced bowel cancer can be as low as 10%.
Read the full story | THE GUARDIAN
